So does anyone have the latest on Vaxil's (Israeli company) immunotherapy approaches?
A few years ago it was mooted as "the great white hope for a cure" but Cancer Reearch UK was very sceptical at the time then over the last two years I have seen reports that it is looking good in Stage II(?) trials with a 90% success rate. Then the latest was that even with that we are six years from mainstream :(
It sounds too good to be true but worth trying to hang on for :)